Found: 27
Select item for more details and to access through your institution.
Performance of the plasma Aβ42/Aβ40 ratio, measured with a novel HPLC-MS/MS method, as a biomarker of amyloid PET status in a DPUK-KOREAN cohort.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00911-7
- By:
- Publication type:
- Article
The global Alzheimer's Association round robin study on plasma amyloid β methods.
- Published in:
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2021, v. 13, n. 1, p. 1, doi. 10.1002/dad2.12242
- By:
- Publication type:
- Article
The Aβ42/Aβ40 ratio in plasma is associated with amyloid‐PET status and rate of progression in individuals with subjective cognitive decline: The Fundació ACE Healthy Brain Initiative: Biomarkers (non‐neuroimaging) / plasma/serum/urine biomarkers
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045780
- By:
- Publication type:
- Article
Safety, tolerability and immunogenicity of an active anti‐Aβ40 vaccine (ABvac40) in patients with amnestic mild cognitive impairment (A‐MCI) or very mild alzheimer's disease (VM‐AD): A randomized, double‐blind, placebo‐controlled, phase II trial: Human/Human trials: Anti‐amyloid
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045720
- By:
- Publication type:
- Article
O1‐07‐01: LONGITUDINAL EVALUATION OF THE NATURAL HISTORY OF Aβ IN PLASMA AND BRAIN.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P210, doi. 10.1016/j.jalz.2019.06.4553
- By:
- Publication type:
- Article
P4‐189: ABVAC40 TREATMENT IN DOGS INDUCES SPECIFIC ANTIBODY RESPONSE AND INCREMENT OF Aβ40 LEVELS IN PLASMA.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1512, doi. 10.1016/j.jalz.2018.06.2594
- By:
- Publication type:
- Article
ANTI-AβX-40 ANTIBODIES EXERT NEUROPROTECTIVE EFFECT AGAINST Aβ-OLIGOMER TOXICITY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1439, doi. 10.1016/j.jalz.2017.06.2255
- By:
- Publication type:
- Article
CORRELATIONS BETWEEN PLASMA AND BRAIN BETA-AMYLOID LEVELS IN INDIVIDUALS WITH SUBJECTIVE COGNITIVE DECLINE: THE FUNDACIÓ ACE HEALTHY BRAIN INITIATIVE (FACEHBI).
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1027, doi. 10.1016/j.jalz.2017.06.1446
- By:
- Publication type:
- Article
AN ACTIVE ANTI-AB40 VACCINE (ABVAC40) PROVED TO BE SAFE AND IMMUNOGENIC IN THE PHASE I CLINICAL TRIAL.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P199, doi. 10.1016/j.jalz.2016.06.348
- By:
- Publication type:
- Article
Total plasma Aβ42/40 ratio is an early biomarker of Alzheimer’s disease progression.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P871, doi. 10.1016/j.jalz.2015.08.067
- By:
- Publication type:
- Article
Cognitive composites and prodromal Alzheimer’s disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P707, doi. 10.1016/j.jalz.2015.06.1567
- By:
- Publication type:
- Article
Beta-amyloid-17 is a major beta-amyloid fragment isoform in cerebrospinal fluid and blood that shows diagnostic value
- Published in:
- 2012
- By:
- Publication type:
- Abstract
Aβ blood levels and Alzheimer's disease.
- Published in:
- 2011
- By:
- Publication type:
- Abstract
Early diagnosis and preventive treatment of Alzheimer's with isoform-specific Aβ antibodies
- Published in:
- 2010
- By:
- Publication type:
- Abstract
Immunization of dogs with C-terminal sequences of beta-amyloid protein is safe and depletes the protein from the blood
- Published in:
- 2009
- By:
- Publication type:
- Abstract
The deposition of Aß40 in the brain is pathognomonic for Alzheimer-type dementia in Down syndrome
- Published in:
- 2009
- By:
- Publication type:
- Abstract
P4-157: Neurofibrillary tangles of Aβ40 in Alzheimer brains
- Published in:
- 2008
- By:
- Publication type:
- Abstract
Neprilysin Is Poorly Expressed in the Prefrontal Cortex of Aged Dogs with Cognitive Dysfunction Syndrome.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Neprilysin Is Poorly Expressed in the Prefrontal Cortex of Aged Dogs with Cognitive Dysfunction Syndrome.
- Published in:
- International Journal of Alzheimer's Disease, 2014, p. 1, doi. 10.1155/2014/483281
- By:
- Publication type:
- Article
Reliable Measurements of the β-Amyloid Pool in Blood Could Help in the Early Diagnosis of AD.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Reliable Measurements of the β-Amyloid Pool in Blood Could Help in the Early Diagnosis of AD.
- Published in:
- International Journal of Alzheimer's Disease, 2012, p. 1, doi. 10.1155/2012/604141
- By:
- Publication type:
- Article
Blood Amyloid Beta Levels in Healthy, Mild Cognitive Impairment and Alzheimer’s Disease Individuals: Replication of Diastolic Blood Pressure Correlations and Analysis of Critical Covariates.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0081334
- By:
- Publication type:
- Article
Blood Markers in Healthy-Aged Nonagenarians: A Combination of High Telomere Length and Low Amyloidβ Are Strongly Associated With Healthy Aging in the Oldest Old.
- Published in:
- Frontiers in Aging Neuroscience, 2018, p. N.PAG, doi. 10.3389/fnagi.2018.00380
- By:
- Publication type:
- Article
Safety, tolerability and immunogenicity of an active anti-Aβ<sub>40</sub> vaccine (ABvac40) in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase I trial.
- Published in:
- Alzheimer's Research & Therapy, 2018, v. 10, p. 1, doi. 10.1186/s13195-018-0340-8
- By:
- Publication type:
- Article
Detecting amyloid positivity in early Alzheimer's disease using combinations of plasma Aβ42/Aβ40 and p‐tau.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 2, p. 283, doi. 10.1002/alz.12395
- By:
- Publication type:
- Article
Aβ42/Aβ40 ratio in plasma predicts amyloid‐PET status in amnestic‐MCI patients.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.057231
- By:
- Publication type:
- Article
Detecting amyloid positivity in early Alzheimer disease using plasma biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.052117
- By:
- Publication type:
- Article